The association between catastrophizing and craving in patients with chronic pain prescribed opioid therapy: A preliminary analysis

Pain Medicine (United States)

Volumn 15, Issue 10, 2014, Pages 1757-1764

  Martel, Marc O ^a   Jamison, Robert N ^a   Wasan, Ajay D ^b   Edwards, Robert R ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Catastrophizing; Chronic pain; Craving; Opioids; Prescription opioid misuse

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; MUSCLE RELAXANT AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE;

ADULT; ARTICLE; BACKACHE; CATASTROPHIZING; CHRONIC PAIN; CROSS-SECTIONAL STUDY; DEPRESSION; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPOTHESIS; MAJOR CLINICAL STUDY; MALE; MUSCLE; NECK PAIN; PAIN INTENSITY; PRESCRIPTION; SELF REPORT; WITHDRAWAL SYNDROME; CRAVING; MIDDLE AGED; OPIATE ADDICTION; PHYSIOLOGY; PSYCHOLOGY;

CATASTROPHIZATION; CHRONIC PAIN; CRAVING; CROSS-SECTIONAL STUDIES; DEPRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; OPIOID-RELATED DISORDERS; SELF REPORT;

EID: 84911950430     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/pme.12416     Document Type: Article

References (80)

1. Turk DC, Swanson KS, Gatchel RJ. Predicting opioid misuse by chronic pain patients: A systematic review and literature synthesis. Clin J Pain 2008;24:497-508.
2. Michna E, Ross EL, Hynes WL, etal. Predicting aberrant drug behavior in patients treated for chronic pain: Importance of abuse history. J Pain Symptom Manage 2004;28:250-258.
3. Fleming MF, Davis J, Passik SD. Reported lifetime aberrant drug-taking behaviors are predictive of current substance use and mental health problems in primary care patients. Pain Med 2008;9:1098-1106.
4. Katz N, Fanciullo GJ. Role of urine toxicology testing in the management of chronic opioid therapy. Clin J Pain 2002;18:S76-82.
5. Ballantyne JC, LaForge KS. Opioid dependence and addiction during opioid treatment of chronic pain. Pain 2007;129:235-255.
6. Chou R, Ballantyne JC, Fanciullo GJ, Fine PG, Miaskowski C. Research gaps on use of opioids for chronic noncancer pain: Findings from a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. J Pain 2009;10:147-159.
7. Dunn KM, Saunders KW, Rutter CM, etal. Opioid prescriptions for chronic pain and overdose: A cohort study. Ann Intern Med 2010;152:85-92.
8. Gallagher RM, Rosenthal LJ. Chronic pain and opiates: Balancing pain control and risks in long-term opioid treatment. Arch Phys Med Rehabil 2008;89:S77-82.
9. Passik SD, Lowery A. Psychological variables potentially implicated in opioid-related mortality as observed in clinical practice. Pain Med 2011;12(suppl 2):S36-42.
10. Webster LR, Cochella S, Dasgupta N, etal. An analysis of the root causes for opioid-related overdose deaths in the United States. Pain Med 2011;12(suppl 2):S26-35.
11. Martel MO, Dolman AJ, Edwards RR, Jamison RN, Wasan AD. The association between negative affect and prescription opioid misuse in patients with chronic pain: The mediating role of opioid craving. J Pain 2014;15:90-100.
12. Wasan AD, Butler SF, Budman SH, etal. Does report of craving opioid medication predict aberrant drug behavior among chronic pain patients? Clin J Pain 2009;25:193-198.
13. Wasan AD, Ross EL, Michna E, etal. Craving of prescription opioids in patients with chronic pain: A longitudinal outcomes trial. J Pain 2012;13:146-154.
14. Butler SF, Fernandez K, Benoit C, Budman SH, Jamison RN. Validation of the revised Screener and Opioid Assessment for Patients with Pain (SOAPP-R). J Pain 2008;9:360-372.
15. Skinner MD, Aubin HJ. Craving's place in addiction theory: Contributions of the major models. Neurosci Biobehav Rev 2010;34:606-623.
16. Tiffany ST, Wray JM. The clinical significance of drug craving. Ann N Y Acad Sci 2012;1248:1-17.
17. Edwards RR, Bingham CO 3rd, Bathon J, Haythornthwaite JA. Catastrophizing and pain in arthritis, fibromyalgia, and other rheumatic diseases. Arthritis Rheum 2006;55:325-332.
18. Edwards RR, Cahalan C, Mensing G, Smith M, Haythornthwaite JA. Pain, catastrophizing, and depression in the rheumatic diseases. Nat Rev Rheumatol 2011;7:216-224.
19. Keefe FJ, Lefebvre JC, Egert JR, etal. The relationship of gender to pain, pain behavior, and disability in osteoarthritis patients: The role of catastrophizing. Pain 2000;87:325-334.
20. Sullivan M, Bishop S, Pivik J. The pain catastrophizing scale: Development and validation. Psychol Assess 1995;7:524-532.
21. Sullivan MJ, Thorn B, Haythornthwaite JA, etal. Theoretical perspectives on the relation between catastrophizing and pain. Clin J Pain 2001;17:52-64.
22. de Boer MJ, Struys MM, Versteegen GJ. Pain-related catastrophizing in pain patients and people with pain in the general population. Eur J Pain 2012;16:1044-1052.
23. Severeijns R, Vlaeyen JW, van den Hout MA, Picavet HS. Pain catastrophizing is associated with health indices in musculoskeletal pain: A cross-sectional study in the Dutch community. Health Psychol 2004;23:49-57.
24. Wideman TH, Sullivan MJ. Differential predictors of the long-term levels of pain intensity, work disability, healthcare use, and medication use in a sample of workers' compensation claimants. Pain 2011;152:376-383.
25. Jacobsen PB, Butler RW. Relation of cognitive coping and catastrophizing to acute pain and analgesic use following breast cancer surgery. J Behav Med 1996;19:17-29.
26. Edwards RR, Wasan AD, Michna E, etal. Elevated pain sensitivity in chronic pain patients at risk for opioid misuse. J Pain 2011;12:953-963.
27. Ferrari R, Capraro M, Visentin M. Risk factors in opioid treatment of chronic noncancer pain: A multidisciplinary assessment. In: Gabor B, Noe CE, eds. Pain Management: Current Issues and Opinions. Rijeka: Intech; 2012:419-459.
28. Martel MO, Wasan AD, Jamison RN, Edwards RR. Catastrophic thinking and increased risk for prescription opioid misuse in patients with chronic pain. Drug Alcohol Depend 2013;132:335-341.
29. Jamison RN, Link CL, Marceau LD. Do pain patients at high risk for substance misuse experience more pain? A longitudinal outcomes study. Pain Med 2009;10:1084-1094.
30. Morasco BJ, Turk DC, Donovan DM, Dobscha SK. Risk for prescription opioid misuse among patients with a history of substance use disorder. Drug Alcohol Depend 2013;127:193-199.
31. Tan G, Jensen MP, Thornby JI, Shanti BF. Validation of the brief pain inventory for chronic nonmalignant pain. J Pain 2004;5:133-137.
32. Jensen MP, Dworkin RH, Gammaitoni AR, etal. Do pain qualities and spatial characteristics make independent contributions to interference with physical and emotional functioning? J Pain 2006;7:644-653.
33. Butler SF, Budman SH, Fernandez KC, Fanciullo GJ, Jamison RN. Cross-validation of a screener to predict opioid misuse in chronic pain patients (SOAPP-R). J Addict Med 2009;3:66-73.
34. Sullivan MJ, Lynch ME, Clark AJ. Dimensions of catastrophic thinking associated with pain experience and disability in patients with neuropathic pain conditions. Pain 2005;113:310-315.
35. Beck A, Steer R, Brown GK. Manual for the Beck Depression Inventory-II. San Antonio, TX: Psychological Corporation; 1996.
36. Poole H, Bramwell R, Murphy P. Factor structure of the Beck depression inventory-II in patients with chronic pain. Clin J Pain 2006;22:790-798.
37. Sullivan MJ, Stanish WD. Psychologically based occupational rehabilitation: The Pain-Disability Prevention Program. Clin J Pain 2003;19:97-104.
38. Vowles KE, Gross RT, Sorrell JT. Predicting work status following interdisciplinary treatment for chronic pain. Eur J Pain 2004;8:351-358.
39. Quartana PJ, Campbell CM, Edwards RR. Pain catastrophizing: A critical review. Expert Rev Neurother 2009;9:745-758.
40. Sullivan MJL, Martel MO. Processes underlying the relation between catastrophizing and chronic pain: Implications for intervention. In: Hasenbring M, Rusu A, Turk DC, eds. From Acute to Chronic Back Pain: Risk factors, Mechanisms and Clinical Implications. Oxford: Oxford University Press; 2011:251-267.
41. Kober H, Kross EF, Mischel W, Hart CL, Ochsner KN. Regulation of craving by cognitive strategies in cigarette smokers. Drug Alcohol Depend 2010;106:52-55.
42. O'Connell KA, Hosein VL, Schwartz JE, Leibowitz RQ. How does coping help people resist lapses during smoking cessation? Health Psychol 2007;26:77-84.
43. Shiffman S, Paty JA, Gnys M, Kassel JA, Hickcox M. First lapses to smoking: Within-subjects analysis of real-time reports. J Consult Clin Psychol 1996;64:366-379.
44. d'Acremont M, Van der Linden M. How is impulsivity related to depression in adolescence? Evidence from a French validation of the cognitive emotion regulation questionnaire. J Adolesc 2007;30:271-282.
45. Muris P, Meesters C, van den Hout A, etal. Personality and temperament correlates of pain catastrophizing in young adolescents. Child Psychiatry Hum Dev 2007;38:171-181.
46. Dawe S, Loxton NJ. The role of impulsivity in the development of substance use and eating disorders. Neurosci Biobehav Rev 2004;28:343-351.
47. Powell J, Bradley B, Gray J. Classical conditioning and cognitive determinants of subjective craving for opiates: An investigation of their relative contributions. Br J Addict 1992;87:1133-1144.
48. Zilberman ML, Tavares H, Hodgins DC, el-Guebaly N. The impact of gender, depression, and personality on craving. J Addict Dis 2007;26:79-84.
49. Westen D, Shedler J. Revising and assessing axis II, Part II: Toward an empirically based and clinically useful classification of personality disorders. Am J Psychiatry 1999;156:273-285.
50. Zittel Conklin C, Westen D. Borderline personality disorder in clinical practice. Am J Psychiatry 2005;162:867-875.
51. Selby EA, Anestis MD, Bender TW, Joiner TE Jr. An exploration of the emotional cascade model in borderline personality disorder. J Abnorm Psychol 2009;118:375-387.
52. Selby EA, Joiner TE Jr. Cascades of emotion: The emergence of borderline personality disorder from emotional and behavioral dysregulation. Rev Gen Psychol 2009;13:219-229.
53. Shedler J, Westen D. Refining personality disorder diagnosis: Integrating science and practice. Am J Psychiatry 2004;161:1350-1365.
54. Trull TJ, Sher KJ, Minks-Brown C, Durbin J, Burr R. Borderline personality disorder and substance use disorders: A review and integration. Clin Psychol Rev 2000;20:235-253.
55. Franken IH. Drug craving and addiction: Integrating psychological and neuropsychopharmacological approaches. Prog Neuropsychopharmacol Biol Psychiatry 2003;27:563-579.
56. Goldstein RZ, Volkow ND. Drug addiction and its underlying neurobiological basis: Neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry 2002;159:1642-1652.
57. Koob GF, Volkow ND. Neurocircuitry of addiction. Neuropsychopharmacology 2010;35:217-238.
58. Volkow ND, Fowler JS, Wang GJ. The addicted human brain: Insights from imaging studies. J Clin Invest 2003;111:1444-1451.
59. Williams TM, Davies SJ, Taylor LG, etal. Brain opioid receptor binding in early abstinence from alcohol dependence and relationship to craving: An [11C]diprenorphine PET study. Eur Neuropsychopharmacol 2009;19:740-748.
60. Volkow ND, Baler RD. Addiction science: Uncovering neurobiological complexity. Neuropharmacology 2014;76:235-249.
61. Gracely RH, Geisser ME, Giesecke T, etal. Pain catastrophizing and neural responses to pain among persons with fibromyalgia. Brain 2004;127:835-843.
62. Seminowicz DA, Davis KD. Cortical responses to pain in healthy individuals depends on pain catastrophizing. Pain 2006;120:297-306.
63. George O, Koob GF. Control of craving by the prefrontal cortex. Proc Natl Acad Sci U S A 2013;110:4165-4166.
64. Sinha R. How does stress increase risk of drug abuse and relapse? Psychopharmacology (Berl) 2001;158:343-359.
65. Gorelick DA, Kim YK, Bencherif B, etal. Imaging brain mu-opioid receptors in abstinent cocaine users: Time course and relation to cocaine craving. Biol Psychiatry 2005;57:1573-1582.
66. Zubieta JK, Gorelick DA, Stauffer R, etal. Increased mu opioid receptor binding detected by PET in cocaine-dependent men is associated with cocaine craving. Nat Med 1996;2:1225-1229.
67. Shi J, Li SX, Zhang XL, etal. Time-dependent neuroendocrine alterations and drug craving during the first month of abstinence in heroin addicts. Am J Drug Alcohol Abuse 2009;35:267-272.
68. Kiefer F, Horntrich M, Jahn H, Wiedemann K. Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Psychopharmacology (Berl) 2002;162:433-437.
69. Campbell CM, Edwards RR. Mind-body interactions in pain: The neurophysiology of anxious and catastrophic pain-related thoughts. Transl Res 2009;153:97-101.
70. Sinha R, Talih M, Malison R, etal. Hypothalamic-pituitary-adrenal axis and sympatho-adreno-medullary responses during stress-induced and drug cue-induced cocaine craving states. Psychopharmacology (Berl) 2003;170:62-72.
71. Ciccocioppo R. The role of serotonin in craving: From basic research to human studies. Alcohol Alcohol 1999;34:244-253.
72. Brady KT, Lydiard RB, Ballenger JC, etal. CSF opioids in panic disorder. Biol Psychiatry 1991;30:512-514.
73. Love TM, Stohler CS, Zubieta JK. Positron emission tomography measures of endogenous opioid neurotransmission and impulsiveness traits in humans. Arch Gen Psychiatry 2009;66:1124-1134.
74. Koob GF, Le Moal M. Drug abuse: Hedonic homeostatic dysregulation. Science 1997;278:52-58.
75. Lutz PE, Kieffer BL. Opioid receptors: Distinct roles in mood disorders. Trends Neurosci 2013;36:195-206.
76. Rohleder N, Nater UM, Wolf JM, Ehlert U, Kirschbaum C. Psychosocial stress-induced activation of salivary alpha-amylase: An indicator of sympathetic activity? Ann N Y Acad Sci 2004;1032:258-263.
77. New AS, Goodman M, Triebwasser J, Siever LJ. Recent advances in the biological study of personality disorders. Psychiatr Clin North Am 2008;31:441-461, vii.
78. Davidson RJ, Lewis DA, Alloy LB, etal. Neural and behavioral substrates of mood and mood regulation. Biol Psychiatry 2002;52:478-502.
79. Friedel RO. Dopamine dysfunction in borderline personality disorder: A hypothesis. Neuropsychopharmacology 2004;29:1029-1039.
80. Carver CS, Miller CJ. Relations of serotonin function to personality: Current views and a key methodological issue. Psychiatry Res 2006;144:1-15.